Autoimmune Diseases of the Nervous System Clinical Trials

19 clinical trials for Autoimmune Diseases of the Nervous System across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Biomarkers in Autoimmune Disease of Nervous System — RECRUITING
• A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases — RECRUITING · PHASE1
• JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders — RECRUITING · NA
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System — RECRUITING · PHASE1
• Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS — RECRUITING · PHASE3
• Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study — NOT_YET_RECRUITING · NA
• Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis — COMPLETED · NA
• Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis — TERMINATED · PHASE1
• Aerobic Exercise for Remyelination in Multiple Sclerosis — COMPLETED · PHASE1
• IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis — SUSPENDED · PHASE1
• Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study — COMPLETED · NA
• Predictors and Prognostic Factors of Myasthenia Gravis Outcome — OTHER
• Power Training in Older Multiple Sclerosis Patients — OTHER · NA
• Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination — OTHER
• Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab — COMPLETED
• A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) — COMPLETED · PHASE4
• Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis — WITHDRAWN · NA
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis — COMPLETED · PHASE2
• Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis — COMPLETED · PHASE1

Refine this search